Oppenheimer Reiterates Outperform on NuCana, Maintains $150 Price Target
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Leland Gershell has reiterated an Outperform rating on NuCana (NASDAQ:NCNA) and maintained a price target of $150.
August 19, 2024 | 3:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer has reiterated its Outperform rating for NuCana, maintaining a $150 price target, indicating confidence in the company's future performance.
The reiteration of an Outperform rating and a high price target by a reputable analyst suggests positive sentiment and potential upside for NuCana's stock. This could lead to increased investor interest and a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100